Revamping Investment Holdings: Lombard Odier's 13F Q2 2016 vs. Q3 2016
Ava Hoppe | 2 May, 2023
Are you an investor looking for a reliable source for investment opportunities? Do you want to know which stocks are driving the current market trends? In this article, we will examine Lombard Odier Transatlantic, Limited Partnership's Q2 2016 vs. Q3 2016 13F holdings comparison to provide you with valuable insights into the changes that occurred in their investment portfolio.
For those unfamiliar with the term, a 13F form is a quarterly filing required by the Securities and Exchange Commission (SEC) for institutional investment managers with assets under management of over $100 million. These filings provide transparency into the investment holdings of institutions like Lombard Odier.
Issuer Name and Option Type
Looking into Lombard Odier's portfolio, the first stock that catches the eye is Alphabet Inc., with an unchanged 5,445 shares in Q2 and Q3 of 2016. IQ shares were available in the issuer's portfolio.
Another notable change in the portfolio was Praxair Inc.'s addition, with 3,360 shares bought in Q3 2016, increasing the total number of shares to 33,510.
Value Generated
Coming to the value of the investments, Lombard Odier's shares in Alphabet Inc. saw a significant increase in value in Q3 2016, with a 14.3% increase from $3.826 million in Q2 2016 to $4.372 million in Q3 2016.
Other notable increases in value were Mondelez Intl Inc. (18.3%), Johnson & Johnson (-4.5%), WisdomTree TR (8.6%), and UBS Group AG (3.7%).
On the other hand, Stericycle Inc. experienced the most significant decrease in value, with a drop of 39.1% from $1.972 million to $1.2 million in Q3 2016.
Percentage Change
Overall, Lombard Odier's changes in holdings show an inclination towards diverse investment options. They have shown a 100% increase in the number of shares invested in the SPDR S&P 500 ETF Trust, a 49.3% increase in Gilead Sciences Inc., and a 35.4% increase in shares of National Oilwell Varco Inc.
However, the portfolio also reflects a decline in holdings in companies like Stericycle Inc., with a drop of 50.7% in the number of shares held and a 36% decline in the PIMCO ETF Trust.
Final Thoughts
While past performance cannot entirely predict future results, analyzing Lombard Odier's 13F report can provide us with an insight perspective about their portfolio performance. It also gives investors some guidelines on additional opportunities in the market. As an investor, it's always important to keep up-to-date with the current market trends and changing portfolio performances.
Other Posts
- When Cashmere Kings Court Modern Moguls: Dawson-Forté's Stylish Business Leap
- Baldwin Brothers LLC/Ma Q2 2023 vs. Q3 2023 13F Holdings Comparison
- **Navigating the Fusion of Giants: How Inrad Optics' $19 Million Journey Will Shape the Future of Tech**
- Titus Wealth Management Q1 2022 vs. Q2 2022 13F Holdings Comparison
- Sheridan Capital Partners Closes Fund III at $575 Million and Expands Healthcare Investments
- Investment Report: Markston International LLC Q3 2021 vs. Q4 2021
- **Title: Navidea Biopharmaceuticals Files Form 15, Streamlining Reporting Obligations for Strategic Focus**
- The Top Holdings Changes of Traynor Capital Management: A Q4 2022 vs. Q1 2023 Comparison
- Making Sense of Ferguson Wellman Capital's Q4 2022 vs. Q1 2023 13F Holdings Data
- Transforming Portfolios: A Look at Circle Road Advisors' Q1 2020 vs. Q2 2020 13F Holdings Comparison